𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pruritus secondary to hydroxyurea therapy in a woman with polycythemia vera

✍ Scribed by Evan Vosburgh

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
67 KB
Volume
41
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pruritus in polycythemia vera is associa
Pruritus in polycythemia vera is associated with a lower risk of arterial thrombosis
✍ Naseema Gangat; Jacob J. Strand; Terra L. Lasho; Chin-Yang Li; Animesh Pardanani πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 72 KB πŸ‘ 1 views

## Abstract Among 418 patients with polycythemia vera seen at our institution and in whom pruritus history was recorded, the presence of pruritus at diagnosis was documented in 131 (31%) and its absence in 287 (69%). Pruritus was less frequently reported by smokers (12% vs. 24%; __P__ = 0.004) and

Leukemogenic risk of hydroxyurea therapy
Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
✍ Nand, Sucha; Stock, Wendy; Godwin, John; Fisher, Susan Gross πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 417 KB πŸ‘ 2 views

In polycythemia Vera (PV), treatment with chlorambucil and radioactive phosphorus (p32) increases the risk of leukemic transformation from 1% to 13-14%. This risk has been estimated to be 1-5.9% with hydroxyurea (HU) therapy. When compared with historical controls, the risk with use of HU does not a

Ξ±-2a interferon therapy and antibody for
Ξ±-2a interferon therapy and antibody formation in patients with essential thrombocythemia and polycythemia vera with thrombocytosis
✍ E. TΓΆrnebohm-Roche; M. Merup; D. Lockner; Dr. C. Paul πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 479 KB πŸ‘ 1 views

In ten patients with essential thrombocythemia and polycythemia Vera with thrombocytosis we have investigated the therapeutic effect of recombinant a-2a interferon (Roceron-A@) given subcutaneously in a maintenance dosage of 3 million units three times weekly. The aim was to normalize the platelet